This is science, not kindergarten. You can't draw a cause and effect relationship without a control group....The 10 patients who are still in the trial might all have survived without treatment. There is only one conclusion that seems reasonable based on the very little data presented.
The trial is meeting the goal of a ph-I study...its proving safety. If people started suffering Adverse Events (AE) or death after taking the treatment, then you have to stop. Thankfully there's only been one death, hopefully it had nothing to do with the treatment...and I assume it didn't.
But to infer that the reason the 6 patients dosed longer than 6.2 months are still alive, and the 5 dosed less than 6.2 months as well, that its due to Ziopharm's treatment....you can't do that and only an idiot would.
Yes they're receiving treatment, and yes they're still alive...but that doesn't mean one led to the other. Using that logic one could say that as the population of whales has decreased world wide, the incidence of divorce has increased in the United States, ergo killing whales causes divorce...or divorcing causes whales to die.
Obviously that's ridiculous...which is why you need control and placebo groups if you want to draw cause and effect relationships.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
Recent TCRT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 09:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:00:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:57:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:46:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:44:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:05:27 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:43:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:58:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:47:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:30:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:25:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:00:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 12:30:01 PM
- Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives • GlobeNewswire Inc. • 11/14/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:01:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:34:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/01/2023 04:20:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:37:25 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM